LeukoDx announces Mark Chess and Seymour Liebman to Board after securing $7M financing round led by Axcel Partners
– ISRAEL – LeukoDx Inc., the creator of the Accellix automated flow cytometry platform, today announced that it has secured $7 million in new financing from Axcel Partners, a US-based private equity group, and individual investors.…